Evaluation of Outcomes From Treatment of Benign or Malignant Gastrointestinal Diseases
1 other identifier
observational
1,000
1 country
1
Brief Summary
This study will be a retrospective, registry study collecting data of patients who were diagnosed with benign or malignant gastrointestinal diseases. Data will be collected from patient's chart retrospectively once the patients have completed proper treatment follow up with physicians' practice.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Jan 2021
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
November 18, 2020
CompletedStudy Start
First participant enrolled
January 7, 2021
CompletedFirst Posted
Study publicly available on registry
November 10, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 17, 2030
ExpectedStudy Completion
Last participant's last visit for all outcomes
May 17, 2030
April 22, 2026
April 1, 2026
9.4 years
November 18, 2020
April 17, 2026
Conditions
Outcome Measures
Primary Outcomes (4)
Overall survival
from day of diagnosis or procedure to death date
Jan 2005 - Jan 2030
Overall symptom
Difficulty swallowing, Heartburn, Regurgitation, Chest pain, Weight Loss, Quality of life
Jan 2005 - Jan 2030
Mortality
death or life
Jan 2005 - Jan 2030
Morbidity
yes or no to individual disease
Jan 2005 - Jan 2030
Eligibility Criteria
Patients who were diagnosed with benign or malignant gastrointestinal diseases.
You may qualify if:
- All patients diagnosed and treated for gastrointestinal diseases, benign or malignant from 2005 to 2030.
- Age ≥18 years
You may not qualify if:
- Patients that are not diagnosed with or treated for gastrointestinal diseases
- Age \<18 years
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Methodist Richardson Medical Center
Richardson, Texas, 75082, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Dhiresh R Jeyarajah
Methodist Health System
Study Design
- Study Type
- observational
- Observational Model
- OTHER
- Time Perspective
- RETROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
November 18, 2020
First Posted
November 10, 2021
Study Start
January 7, 2021
Primary Completion (Estimated)
May 17, 2030
Study Completion (Estimated)
May 17, 2030
Last Updated
April 22, 2026
Record last verified: 2026-04
Data Sharing
- IPD Sharing
- Will not share